Researcher.Life Logo

Journal of Neuroimmunology : Impact Factor & More

eISSN: 1872-8421pISSN: 0165-5728

Aims and Scope of Journal of Neuroimmunology

The Journal of Neuroimmunology is an Elsevier journal established in 1981 which focuses on the relationship between the nervous system and the immune system. The editor-in-chief is Michael Racke (Ohio State University College of Medicine). According to the Journal Citation Reports, the journal has a 2012 impact factor of 3.033, ranking it 116th out of 252 journals in the category "Neurosciences". Less

Key Metrics

CiteScore
5.4
Impact Factor
< 5
SJR
Q2Neurology
SNIP
0.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Neuroimmunology

Journal of Neuroimmunology Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Neuroimmunology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Neuroimmunology

Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series.
  • 1 Aug 2026
  • Journal of neuroimmunology
Re-challenge of immune checkpoint inhibitor after ICI-encephalitis: A case report.
  • 1 Aug 2026
  • Journal of neuroimmunology
Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis
  • 1 Aug 2026
  • Journal of Neuroimmunology
Targeted proteomic profiling of serum and CSF reveals CASP-8 as a candidate biomarker in anti-NMDAR encephalitis.
  • 1 Aug 2026
  • Journal of neuroimmunology
Real-world evidence on utilization and clinical outcomes of efgartigimod in patients with generalized myasthenia gravis.
  • 1 Aug 2026
  • Journal of neuroimmunology
Metalloproteinase imbalance in HIV-1: Subtype comparison in CSF and serum.
  • 1 Aug 2026
  • Journal of neuroimmunology
Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series.
  • 1 Aug 2026
  • Journal of neuroimmunology
Re-challenge of immune checkpoint inhibitor after ICI-encephalitis: A case report.
  • 1 Aug 2026
  • Journal of neuroimmunology
Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis
  • 1 Aug 2026
  • Journal of Neuroimmunology
Targeted proteomic profiling of serum and CSF reveals CASP-8 as a candidate biomarker in anti-NMDAR encephalitis.
  • 1 Aug 2026
  • Journal of neuroimmunology
Real-world evidence on utilization and clinical outcomes of efgartigimod in patients with generalized myasthenia gravis.
  • 1 Aug 2026
  • Journal of neuroimmunology
Metalloproteinase imbalance in HIV-1: Subtype comparison in CSF and serum.
  • 1 Aug 2026
  • Journal of neuroimmunology

FAQs on Journal of Neuroimmunology